Simplex Trading
ITCI

Simplex Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Simplex Trading’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,300
Closed -$124K – 10013
2025
Q1 		$124K Buy
12,300
+10,200
+486% +$1.27M ﹤0.01% 4844
2024
Q4 		$175K Sell
2,100
-21,200
-91% -$1.74M ﹤0.01% 4650
2024
Q3 		$1.7M Sell
23,300
-8,900
-28% -$669K ﹤0.01% 2420
2024
Q2 		$2.21M Sell
32,200
-85,900
-73% -$5.96M ﹤0.01% 2104
2024
Q1 		$8.17M Buy
118,100
+69,600
+144% +$4.78M ﹤0.01% 1256
2023
Q4 		$3.47M Buy
48,500
+31,600
+187% +$1.82M ﹤0.01% 1868
2023
Q3 		$880K Buy
16,900
+9,300
+122% +$542K ﹤0.01% 2802
2023
Q2 		$481K Sell
7,600
-49,400
-87% -$3.08M ﹤0.01% 3357
2023
Q1 		$3.09M Buy
57,000
+47,300
+488% +$2.29M ﹤0.01% 1608
2022
Q4 		$513K Sell
9,700
-11,200
-54% -$561K ﹤0.01% 3128
2022
Q3 		$972K Sell
20,900
-3,700
-15% -$193K ﹤0.01% 2675
2022
Q2 		$1.4M Sell
24,600
-30,000
-55% -$1.7M ﹤0.01% 2241
2022
Q1 		$3.34M Sell
54,600
-14,300
-21% -$743K ﹤0.01% 1598
2021
Q4 		$3.61M Buy
68,900
+27,200
+65% +$1.14M ﹤0.01% 1488
2021
Q3 		$1.77M Sell
41,700
-100
-0.2% -$3.48K ﹤0.01% 2310
2021
Q2 		$1.71M Buy
41,800
+41,749
+81,861% +$1.54M ﹤0.01% 2375
2021
Q1 		$173K Sell
51
-107
-68% -$3.71K ﹤0.01% 4967
2020
Q4 		$502K Sell
158
-403
-72% -$10.6K ﹤0.01% 3420
2020
Q3 		$1.44M Sell
561
-287
-34% -$6.55K ﹤0.01% 1851
2020
Q2 		$2.18M Buy
848
+578
+214% +$11.7K ﹤0.01% 1444
2020
Q1 		$414K Sell
270
-1,083
-80% -$23.5K ﹤0.01% 2796
2019
Q4 		$4.64M Buy
1,353
+803
+146% +$9.64K 0.01% 850
2019
Q3 		$410K Sell
550
-830
-60% -$7.96K ﹤0.01% 2819
2019
Q2 		$1.79M Sell
1,380
-51
-4% -$654 ﹤0.01% 1392
2019
Q1 		$1.74M Buy
1,431
+299
+26% +$3.82K ﹤0.01% 1493
2018
Q4 		$1.29M Buy
1,132
+841
+289% +$13.6K ﹤0.01% 1427
2018
Q3 		$631K Sell
291
-70
-19% -$1.46K ﹤0.01% 2385
2018
Q2 		$637K Buy
361
+157
+77% +$3.19K ﹤0.01% 2221
2018
Q1 		$16K Buy
204
+181
+787% +$3.53K ﹤0.01% 3586
2017
Q4 		$6K Sell
23
-89
-79% -$1.37K ﹤0.01% 4396
2017
Q3 		$20K Sell
112
-65
-37% -$954 ﹤0.01% 3177
2017
Q2 		$20K Buy
177
+168
+1,867% +$1.95K ﹤0.01% 3307
2017
Q1 		$4K Sell
9
-629
-99% -$9.1K ﹤0.01% 4842
2016
Q4 		$74K Sell
638
-53
-8% -$748 ﹤0.01% 1785
2016
Q3 		$6K Buy
691
+308
+80% +$12.5K ﹤0.01% 4158
2016
Q2 		$156K Buy
383
+231
+152% +$8.3K 0.01% 1165
2016
Q1 		$22K Buy
152
+27
+22% +$900 ﹤0.01% 2728
2015
Q4 		$126K Sell
125
-67
-35% -$3.38K 0.01% 1182
2015
Q3 		$48K Buy
+192
New +$6.26K ﹤0.01% 2037

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Simplex Trading's ITCI Position: Q2 2025 in Review

Simplex Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,214 shares — an estimated $423K sold.

Simplex Trading first reported a position in ITCI in Q3 2015 and held it in 27 quarters. The position peaked at $2.29M in Q1 2023. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Simplex Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 3,214 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $423K.
  • Simplex Trading first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 27 quarters.
  • Simplex Trading's Intra-Cellular Therapies Inc. position peaked at $2.29M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.